A detailed history of Macroview Investment Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Macroview Investment Management LLC holds 488 shares of ABBV stock, worth $87,840. This represents 0.1% of its overall portfolio holdings.

Number of Shares
488
Previous 474 2.95%
Holding current value
$87,840
Previous $81,000 18.52%
% of portfolio
0.1%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $2,293 - $2,790
14 Added 2.95%
488 $96,000
Q2 2024

Jul 23, 2024

BUY
$154.79 - $180.76 $8,203 - $9,580
53 Added 12.59%
474 $81,000
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $6,872 - $7,830
-43 Reduced 9.27%
421 $76,000
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $13,622 - $15,342
-99 Reduced 17.58%
464 $71,000
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $21,107 - $24,434
158 Added 39.01%
563 $83,000
Q2 2023

Jul 13, 2023

BUY
$132.51 - $164.9 $530 - $659
4 Added 1.0%
405 $54,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $578 - $666
4 Added 1.01%
401 $63,000
Q4 2022

Jan 11, 2023

BUY
$138.31 - $165.87 $414 - $497
3 Added 0.76%
397 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $536 - $615
4 Added 1.03%
394 $53,000
Q2 2022

Jul 20, 2022

BUY
$137.62 - $174.96 $550 - $699
4 Added 1.04%
390 $60,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $395 - $491
3 Added 0.78%
386 $63,000
Q4 2021

Jan 25, 2022

BUY
$107.43 - $135.93 $537 - $679
5 Added 1.32%
383 $52,000
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $425 - $483
4 Added 1.07%
378 $41,000
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $420 - $468
4 Added 1.08%
374 $42,000
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $409 - $450
4 Added 1.09%
370 $40,000
Q4 2020

Jan 29, 2021

BUY
$80.49 - $108.67 $402 - $543
5 Added 1.39%
366 $39,000
Q3 2020

Oct 23, 2020

BUY
$85.91 - $100.83 $343 - $403
4 Added 1.12%
361 $32,000
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $293 - $392
4 Added 1.13%
357 $35,000
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $322 - $488
5 Added 1.44%
353 $27,000
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $288 - $361
4 Added 1.16%
348 $31,000
Q3 2019

Nov 04, 2019

BUY
$62.98 - $75.72 $377 - $454
6 Added 1.78%
344 $26,000
Q2 2019

Jul 23, 2019

BUY
$65.7 - $83.98 $262 - $335
4 Added 1.2%
338 $25,000
Q1 2019

May 09, 2019

BUY
$77.14 - $90.79 $308 - $363
4 Added 1.21%
334 $27,000
Q4 2018

Feb 07, 2019

BUY
$77.85 - $96.01 $311 - $384
4 Added 1.23%
330 $30,000
Q3 2018

Nov 02, 2018

SELL
$88.91 - $98.84 $2,934 - $3,261
-33 Reduced 9.19%
326 $31,000
Q2 2018

Jul 31, 2018

BUY
$89.78 - $106.23 $3,501 - $4,142
39 Added 12.19%
359 $33,000
Q1 2018

May 07, 2018

BUY
$92.01 - $123.21 $184 - $246
2 Added 0.63%
320 $30,000
Q4 2017

Jan 25, 2018

BUY
$89.56 - $98.21 $179 - $196
2 Added 0.63%
318 $31,000
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $209 - $267
3 Added 0.96%
316 $28,000
Q2 2017

Aug 11, 2017

BUY
N/A
313
313 $23,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.